Ondansetron
Product Images NDC 60760-567

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 60760-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

567-10 (Ondansetron 567 10)

567-10 (Ondansetron 567 10)
Packaging label for Ondansetron Orally Disintegrating Tablets USP, 8 mg, with a quantity of 10 tablets. The label shows the NDC 60760-567-10, manufactured by Rising Health, LLC, in Saddle Brook, NJ, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes instructions to store at controlled room temperature (15°-30°C) and notes the product is Rx only.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron showing its molecular framework, including a fused ring system and functional groups indicated by standard chemical notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.